Top Suppliers:I want be here


2204245-48-5

2204245-48-5 structure
2204245-48-5 structure
  • Name: Bamocaftor
  • Chemical Name: N-(Phenylsulfonyl)-6-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2-[(4S)-2,2,4-trimethyl-1-pyrrolidinyl]nicotinamide
  • CAS Number: 2204245-48-5
  • Molecular Formula: C28H32F3N5O4S
  • Molecular Weight: 591.64
  • Catalog: Signaling Pathways Membrane Transporter/Ion Channel CFTR
  • Create Date: 2021-12-20 19:48:52
  • Modify Date: 2025-09-11 15:56:04
  • Bamocaftor (VX-659) is a cystic fibrosis transmembrane conductance regulator (CFTR) corrector designed to restore F508del-CFTR protein function. Bamocaftor can be used combine with Tezacaftor and Ivacaftor in cystic fibrosis research[1].

Name N-(Phenylsulfonyl)-6-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2-[(4S)-2,2,4-trimethyl-1-pyrrolidinyl]nicotinamide
Synonyms N-(Phenylsulfonyl)-6-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2-[(4S)-2,2,4-trimethyl-1-pyrrolidinyl]nicotinamide
3-Pyridinecarboxamide, N-(phenylsulfonyl)-6-[3-[2-[1-(trifluoromethyl)cyclopropyl]ethoxy]-1H-pyrazol-1-yl]-2-[(4S)-2,2,4-trimethyl-1-pyrrolidinyl]-
Description Bamocaftor (VX-659) is a cystic fibrosis transmembrane conductance regulator (CFTR) corrector designed to restore F508del-CFTR protein function. Bamocaftor can be used combine with Tezacaftor and Ivacaftor in cystic fibrosis research[1].
Related Catalog
In Vitro Bamocaftor is a CFTR corrector designed to restore F508del-CFTR protein function[1].
References

[1]. Ghelani DP, et al. Emerging Cystic Fibrosis Transmembrane Conductance Regulator Modulators as New Drugs for Cystic Fibrosis: A Portrait of in Vitro Pharmacology and Clinical Translation.

Density 1.4±0.1 g/cm3
Molecular Formula C28H32F3N5O4S
Molecular Weight 591.64
Exact Mass 591.212708
LogP 5.71
Index of Refraction 1.622
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.